Use access key #2 to skip to page content.
$2.67 0.43 (19.20%)
12/3/2008 4:00 PM

TomoTherapy, Inc. (TOMO)

CAPS Rating:
**

The Company develops, manufactures and sells the Hi Art system, a radiation therapy system for the treatment of a variety of cancers.

View Ticker Page (TOMO)

Results 1 - 10 of 16 :   12

Recs

0

Avatar spikenailz (< 20) Submitted: 7/26/07 11:09 AM : Outperform Start Price: $26.17 TOMO Score: -48.22

They have an awesome cancer zapping product and I don't think cancer is going away anytime in the near future, so they should do very well. How many other companies have done so well so shortly after IPO?

Report this Post Replies: 1 | Reply | Permalink

Recs

2

Avatar PauvrePapillon (99.38) Submitted: 8/01/07 9:38 PM : Underperform Start Price: $24.91 TOMO Score: 48.78

Tomo's losses are accelerating, their revenue is below projections, management is scheming its level best to raid their shareholders equity while post-IPO euphoria has run up their market cap way past a rational valuation AND their technology is yest...

Report this Post Replies: 8 | Reply | Permalink

Recs

2

Avatar badger1978 (23.55) Submitted: 8/04/07 12:44 PM : Underperform Start Price: $23.21 TOMO Score: 49.05

I bought in the day of the IPO at 23.25, thought I was going to make a killing especially when it jumped to 27. the fact that they werent releasing earnings until after the market closed worried me. The moment I read the earnings statement I knew it...

Report this Post Replies: 5 | Reply | Permalink

Recs

1

Avatar mickeekanto (< 20) Submitted: 1/13/08 7:00 PM : Outperform Start Price: $17.80 TOMO Score: -46.86

TOMO had recent strong increases in backlog. They also work off their backlog in about 3 quarters. I'm estimating revs of $67.6M in the quarter ending Dec07. And $72M in the quarter after that. Regarding competition from VAR, it needs to be watched. ...

Report this Post Replies: 2 | Reply | Permalink

Recs

0

Avatar kevinnail (21.18) Submitted: 7/26/07 9:57 AM : Outperform Start Price: $26.30 TOMO Score: -47.96

Look at the numbers and you haveto expect this stock to outperform. With so many cases of cancer and no cure in sight, this company will continue to make big bucks selling their cancer zapping product. This is one of the few companies that has done...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar greenretriever (< 20) Submitted: 4/18/08 10:25 AM : Outperform Start Price: $9.47 TOMO Score: -34.85

The stock is at historical lows, it adjusted it's earnings and is in the process of expansion to China, it is poised to go up!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar beaker28 (41.06) Submitted: 4/19/08 1:46 PM : Outperform Start Price: $9.12 TOMO Score: -33.86

i read an article about it once

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar je2kfool (< 20) Submitted: 6/06/08 12:51 PM : Outperform Start Price: $9.01 TOMO Score: -33.54

staff expertise, market size, demographic change

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Tri3 (< 20) Submitted: 6/25/08 6:08 PM : Outperform Start Price: $8.24 TOMO Score: -34.47

Earnings surprise

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar gridster (30.70) Submitted: 4/10/08 1:29 PM : Outperform Start Price: $14.44 TOMO Score: -45.53

This is a great company involved with perfecting radiation therapy in cancer. They are beginning to sell world wide their tomotherapy machines. There should be a huge potential over the next year for this company

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links